The call provided a mixed outlook, with notable achievements in revenue and innovation but significant challenges in specific segments like Sample Management and international diagnostics due to external factors. While there is progress on strategic initiatives, immediate financial impacts remain a concern.

Company Guidance -

Q3 2025

During the OraSure Technologies Second Quarter 2025 Earnings Conference Call, guidance highlighted several key metrics and strategic priorities. The company reported total revenue of $31.2 million, with core revenue at $30.8 million, surpassing the midpoint of their guidance range. Diagnostics products generated $19.2 million, marking a 3% year-over-year growth, while Sample Management Solutions reported $9.9 million, facing a 22% drop due to a large customer in the Consumer Genetics segment. Excluding this impact, overall core revenue would have increased by 5% year-over-year. The GAAP gross margin was 42.1%, and the non-GAAP gross margin was 43.2%. The company forecasted third-quarter revenue between $27 million and $30 million, influenced by international order trends and the timing of orders from the Together Take Me Home program. Operating expenses were projected to include $20 million in core expenses and $10 million in innovation investments. The company also highlighted significant progress in transitioning manufacturing in-house, expected to enhance operating efficiencies in late 2025 and 2026.

Revenue Achievement

Reported revenue in Q2 was in the top half of the guidance range for both total revenue and core revenue, with diagnostics growing 3% year-over-year.

Innovation Roadmap Progress

Launched HEMAcollect PROTEIN in July to expand the portfolio with new products, specifically targeting proteomic researchers.

Leadership Addition

Anne Messing joined as Chief Commercial Officer, bringing over 25 years of commercial leadership experience.

Transition to Internal Manufacturing

Completed the transition from external contract manufacturing to internal capabilities ahead of schedule, expected to improve operational efficiencies.

GeneDx Agreement Renewal

Renewed agreement with GeneDx, supporting early diagnosis of rare pediatric diseases through genome analysis.

Colli-Pee Device FDA Submission

Strong progress towards a 2025 FDA submission for the Colli-Pee device, targeting a multibillion-dollar global market.

Orasure Technologies (OSUR) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

OSUR Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 05, 2025	2025 (Q3)	-0.19 / -	-0.06	―	―	―
Aug 05, 2025	2025 (Q2)	-0.20 / -0.26	-0.01	-2500.00% (-0.25)	―
May 07, 2025	2025 (Q1)	-0.16 / -0.21	-0.05	-320.00% (-0.16)	―
Feb 25, 2025	2024 (Q4)	-0.06 / -0.14	0.27	-151.85% (-0.41)	―
Nov 06, 2024	2024 (Q3)	-0.08 / -0.06	0.15	-140.00% (-0.21)	―
Aug 06, 2024	2024 (Q2)	>-0.01 / -0.01	-0.07	85.71% (+0.06)	―
May 08, 2024	2024 (Q1)	- / -0.05	0.37	-113.51% (-0.42)	―
Feb 27, 2024	2023 (Q4)	0.09 / 0.27	0.21	28.57% (+0.06)	―
Nov 07, 2023	2023 (Q3)	0.05 / 0.15	0.07	114.29% (+0.08)	―
Aug 03, 2023	2023 (Q2)	-0.07 / -0.07	-0.26	73.08% (+0.19)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

OSUR Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 05, 2025	$3.12	$2.86	-8.33%
May 07, 2025	$2.79	$2.60	-6.81%
Feb 25, 2025	$4.00	$3.06	-23.50%
Nov 06, 2024	$4.40	$4.24	-3.64%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Orasure Technologies (OSUR) report earnings?

Orasure Technologies (OSUR) is schdueled to report earning on Nov 05, 2025, After Close (Confirmed).

What is Orasure Technologies (OSUR) earnings time?

Orasure Technologies (OSUR) earnings time is at Nov 05, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is OSUR EPS forecast?

OSUR EPS forecast for the fiscal quarter 2025 (Q3) is -0.19.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing